Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Janssen

Showing results (141-150 of 198) with videos related to

Pageof 20
Sort By:
Scientific Reports|August 22, 2019
Two Isoforms of the Guanine Nucleotide Exchange Factor, Daple/CCDC88C Cooperate as Tumor SuppressorsJason Ear, Ying Dunkel, Yash Mittal, et al.
Oncoimmunology|September 19, 2017
Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccinationAnnkristin Heine, Chrystel Flores, Heidrun Gevensleben, et al.
Annals of Surgery|January 9, 2013
Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancerMatthias Maak, Iris Simon, Ulrich Nitsche, et al.
Molecular Cancer Therapeutics|January 28, 2022
Tumor Targeting with Bacterial Shiga Toxin B Subunit in Genetic Porcine Models for Colorectal Cancer and OsteosarcomaMaximilian Ehrenfeld, Anna Schrade, Tatiana Flisikowska, et al.
Oncoimmunology|May 4, 2018
PPARγ-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant <i>KRAS</i> miceTobias Gutting, Christian A Weber, Philip Weidner, et al.
Atherosclerosis|August 31, 2015
SASH1, a new potential link between smoking and atherosclerosisHenri Weidmann, Zahia Touat-Hamici, Herve Durand, et al.
Annals of Surgery|August 31, 2013
Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosisUlrich Nitsche, Anina Zimmermann, Christoph Späth, et al.
Gut|April 4, 2023
<i>Helicobacter pylori</i> promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signatureAnna Ralser, Alisa Dietl, Sebastian Jarosch, et al.
Gastroenterology|August 1, 2018
Activated ATF6 Induces Intestinal Dysbiosis and Innate Immune Response to Promote Colorectal TumorigenesisOlivia I Coleman, Elena M Lobner, Sandra Bierwirth, et al.
Journal of the National Cancer Institute|August 10, 2014
Investigation of Schwann cells at neoplastic cell sites before the onset of cancer invasionIhsan Ekin Demir, Alexandra Boldis, Paulo L Pfitzinger, et al.
Pageof 20

Showing results (141-150 of 198) with videos related to

Sort By:
Pageof 20
Scientific Reports|August 22, 2019
Two Isoforms of the Guanine Nucleotide Exchange Factor, Daple/CCDC88C Cooperate as Tumor SuppressorsJason Ear, Ying Dunkel, Yash Mittal, et al.
Oncoimmunology|September 19, 2017
Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccinationAnnkristin Heine, Chrystel Flores, Heidrun Gevensleben, et al.
Annals of Surgery|January 9, 2013
Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancerMatthias Maak, Iris Simon, Ulrich Nitsche, et al.
Molecular Cancer Therapeutics|January 28, 2022
Tumor Targeting with Bacterial Shiga Toxin B Subunit in Genetic Porcine Models for Colorectal Cancer and OsteosarcomaMaximilian Ehrenfeld, Anna Schrade, Tatiana Flisikowska, et al.
Oncoimmunology|May 4, 2018
PPARγ-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant <i>KRAS</i> miceTobias Gutting, Christian A Weber, Philip Weidner, et al.
Atherosclerosis|August 31, 2015
SASH1, a new potential link between smoking and atherosclerosisHenri Weidmann, Zahia Touat-Hamici, Herve Durand, et al.
Annals of Surgery|August 31, 2013
Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosisUlrich Nitsche, Anina Zimmermann, Christoph Späth, et al.
Gut|April 4, 2023
<i>Helicobacter pylori</i> promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signatureAnna Ralser, Alisa Dietl, Sebastian Jarosch, et al.
Gastroenterology|August 1, 2018
Activated ATF6 Induces Intestinal Dysbiosis and Innate Immune Response to Promote Colorectal TumorigenesisOlivia I Coleman, Elena M Lobner, Sandra Bierwirth, et al.
Journal of the National Cancer Institute|August 10, 2014
Investigation of Schwann cells at neoplastic cell sites before the onset of cancer invasionIhsan Ekin Demir, Alexandra Boldis, Paulo L Pfitzinger, et al.
Pageof 20